There are 2949 resources available
Introduction
Presenter: Fortunato Ciardiello
Session: Servier - Can current treatment strategies for mCRC be further optimized?
Resources:
Webcast
Optimizing treatment strategies in first-line mCRC
Presenter: Mark Saunders
Session: Servier - Can current treatment strategies for mCRC be further optimized?
Resources:
Webcast
Extending the continuum of care beyond second-line mCRC
Presenter: Timothy Price
Session: Servier - Can current treatment strategies for mCRC be further optimized?
Resources:
Webcast
Conclusion
Presenter: Fortunato Ciardiello
Session: Servier - Can current treatment strategies for mCRC be further optimized?
Resources:
Webcast
Welcome and introduction
Presenter: Tanja Cufer
Session: Boehringer Ingelheim - Focus on NSCLC treatment options
Resources:
Webcast
Treatments After Progression in the First-Line of Non-Mutated NSCLC Adenocarcinoma
Presenter: Silvia Novello
Session: Boehringer Ingelheim - Focus on NSCLC treatment options
Resources:
Webcast
Uncommon EGFR mutations
Presenter: Xiuning Le
Session: Boehringer Ingelheim - Focus on NSCLC treatment options
Resources:
Webcast
The Future of NSCLC
Presenter: Melissa Johnson
Session: Boehringer Ingelheim - Focus on NSCLC treatment options
Resources:
Webcast
Key insights and closing remarks
Presenter: Tanja Cufer
Session: Boehringer Ingelheim - Focus on NSCLC treatment options
Resources:
Webcast
Challenges in the treatment of prostate cancer
Presenter: Daniel George
Session: Pfizer Oncology - Building a new paradigm in prostate cancer
Resources:
Webcast